Syneos Health Podcast | Asembia's AXS25 Summit: Navigating Modern Market Access Series

The biopharmaceutical drug market is expanding at an unprecedented pace, fueled by groundbreaking innovations and the rapid adoption of new therapies. But with progress comes complexity—soaring costs, evolving regulations, and persistent access challenges. How is the industry adapting to navigate these hurdles? And what strategies are unlocking new opportunities for patients, providers, and innovators alike?

This special series of the Syneos Health Podcast, in collaboration with Asembia's ASX25 Summit, will feature interviews with key thought leaders and industry experts on the ground to explore the dynamic forces shaping the market today.

Scroll down to listen to all available episodes as we uncover key strategies, industry trends and collaborative innovations driving the future of market access and specialty pharmacy.

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.

Episode 1 | Navigating Modern Market Access

In this kickoff episode of our special podcast series in collaboration with Asembia, hosts Michael Sarshad, Managing Director, Commercial Advisory, Syneos Health and Sara Rubin, Senior Vice President, Market Access Strategy at Spherico, a Syneos Health company, unpack the dynamic forces reshaping how therapies reach patients. Recorded ahead of Asembia’s AXS25 Specialty Pharmacy Summit, they dive into the impact of tariffs, the power of AI in streamlining patient support, the ripple effects of the Inflation Reduction Act and how digital transformation is changing the way manufacturers engage population health decision-makers.

Episode 2 | Modernizing Patient Services: AI, Hybrid Models and Innovation Strategy with Greg Morris of CareMetx

In this episode, host Michael Sarshad speaks with Kim Plesnarski, SVP of Market Access and Patient Support Services at Syneos Health and Greg Morris, Chief Strategy Officer at CareMetx. 

They explore the latest trends shaping patient support services—from the surge of AI-powered solutions to the shift toward hybrid hub models. The conversation dives into the challenges of reactive support programs, the need for continual innovation and the nuanced debate between insourcing and outsourcing. 

With practical insights and real-world examples, Kim and Greg share strategies for building scalable, tech-forward patient service models that meet the evolving demands of both patients and providers.

Episode 3 | Holistic Patient Support with Tiara Green of Accessia Health

In this episode, host Michael Sarshad sits down with Tiara Green, President of Accessia Health, to explore the evolving landscape of patient support. 

They discuss how Accessia Health is addressing the growing needs of individuals with rare and chronic conditions—not just through copay assistance, but by tackling social determinants of health like transportation, food insecurity and mental health services. Tiara shares insights on the expanding role of technology, from streamlined eligibility systems to telehealth and AI, and emphasizes the importance of personalized, community-based care. They also dive into provider education, the power of partnerships and how pharma can promote health equity by engaging diverse populations earlier in the care continuum.

Episode 4 | Redefining Market Access: Patient Support, Technology and Pharma Strategy with Rob Truckenmiller of PharmaCord

In this episode, host Sara Rubin sits down with Rob Truckenmiller, the newly appointed CEO of PharmaCord.

Drawing from his deep experience across small, mid-sized and large pharmaceutical companies, Rob explores how market access strategies must evolve to meet today’s healthcare challenges. From the integration of patient services and payer strategies to the role of technology and data in shaping outcomes, Rob shares his perspective on how pharma companies can empower patients, optimize gross-to-net and navigate the complex US healthcare landscape.